Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease

ClinicalTrials.gov ID: NCT02574637

Public ClinicalTrials.gov record NCT02574637. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 4:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MEDI2070 in Subjects With Moderate to Severe Crohn's Disease Who Have Failed or Are Intolerant to Anti-tumor Necrosis Factor-alpha Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Phase 2b study to evaluate the efficacy and safety of brazikumab (MEDI2070) in participants with moderate to severe Crohn's disease who have failed or are intolerant to anti-tumor necrosis factor-alpha (anti-TNFα) therapy.

Study identification

NCT ID
NCT02574637
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
29 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 5, 2016 (Actual)
Primary completion
Jul 28, 2017 (Actual)
Completion
Jan 29, 2018 (Actual)
Last update posted
May 26, 2021

2016 – 2018

United States locations

U.S. sites
52
U.S. states
18
U.S. cities
28
Facility City State ZIP Site status
Arizona Arthritis & Rheumatology Research, PLLC Phoenix Arizona 85037 —
Research Site Phoenix Arizona 85037 —
South Denver Gastroenterology, PC Lone Tree Colorado 80124-5520 —
Research Site Lone Tree Colorado 80124 —
Clinical Research of West Florida - Corporate Clearwater Florida 33765 —
Borland-Groover Clinic Jacksonville Florida 32256 —
Research Site Jacksonville Florida 32256 —
Advanced Pharma CR, LLC Miami Florida 33147 —
Research Site Miami Florida 33147 —
IMIC, Inc. Palmetto Bay Florida 33157 —
Research Site Chicago Illinois 60637 —
University of Chicago Medical Center Chicago Illinois 60637 —
NorthShore University HealthSystem Evanston Illinois 60201 —
Research Site Evanston Illinois 60201 —
Indiana University Indianapolis Indiana 46202 —
Research Site Indianapolis Indiana 46202 —
Cotton-O'Neil Clinical Research Center, Digestive Health Topeka Kansas 66606 —
Research Site Topeka Kansas 66606 —
Graves Gilbert Clinic Bowling Green Kentucky 42101 —
Research Site Bowling Green Kentucky 42101 —
Research Site Louisville Kentucky 40202 —
University of Louisville Louisville Kentucky 40202 —
Clinical Trials of SW Louisiana, LLC Lake Charles Louisiana 70601 —
Research Site Lake Charles Louisiana 70601 —
Clinical Trials Management, LLC Metairie Louisiana 70006 —
Research Site Metairie Louisiana 70006 —
Research Site Ann Arbor Michigan 48109 —
University of Michigan Health System Ann Arbor Michigan 48109 —
Research Site Southfield Michigan 48034 —
Revival Research Institute, LLC Southfield Michigan 48034 —
Mayo Clinic - Rochester Rochester Minnesota 55905 —
Research Site Rochester Minnesota 55905 —
Ehrhardt Clinical Research, LLC Belton Missouri 64012 —
Research Site Belton Missouri 64012 —
New York University Medical Center Great Neck New York 11021 —
Premier Medical Group of the Hudson Valley, PC Poughkeepsie New York 12601 —
Research Site Poughkeepsie New York 12601 —
Research Site Charlotte North Carolina 28205 —
Clinical Inquest Center Ltd Dayton Ohio 45409 —
Research Site Dayton Ohio 45409 —
Donald Guthrie Foundation Sayre Pennsylvania 18840 —
Research Site Sayre Pennsylvania 18840 —
Erlanger Health System Chattanooga Tennessee 37403 —
Research Site Chattanooga Tennessee 37403 —
Research Site Houston Texas 77030 —
University of Texas Health Science Center at Houston Houston Texas 77030 —
Gastroenterology Research of America Houston Texas 77098 —
Research Site Houston Texas 77098 —
Baylor Research Institute Temple Texas 76508-0001 —
Research Site Temple Texas 76508 —
Allegiance Research Specialists, LLC Milwaukee Wisconsin 53226 —
Research Site Wauwatosa Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02574637, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 26, 2021 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02574637 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →